Heart Valve Diseases Clinical Trial
Official title:
Prolonged Cardiopulmonary Bypass (CPB) Time as a Predictive Factor for Acute Gastrointestinal Injury (AGI) After Heart Valve Replacement
NCT number | NCT05498935 |
Other study ID # | CPB-AGI |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 10, 2022 |
Est. completion date | January 2, 2024 |
Verified date | January 2024 |
Source | Hepatopancreatobiliary Surgery Institute of Gansu Province |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
In this retrospective study, the investigators will analyze the correlation between cardiopulmonary bypass (CPB) time and acute gastrointestinal injury (AGI), and the outcomes of AGI in patients undergoing heart valve replacement.
Status | Completed |
Enrollment | 1070 |
Est. completion date | January 2, 2024 |
Est. primary completion date | January 2, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Patients undergoing heart valve replacement surgery with CPB - Age > 18 years and = 70 years Exclusion Criteria: - Patients combined with severe hematological disease, respiratory disease, and other critical diseases - Patients had severe disorder of multiple systems and organs or severe pulmonary hypertension - Have received major gastrointestinal surgery within 5 years - Inflammatory bowel disease (IBD), including ulcerative colitis, Crohn's disease, or colitis - Acute gastroenteritis - Clostridium difficile or Helicobacter pylori infection - Chronic constipation - Peptic ulcer - Polyps in the stomach or intestines - Gastrointestinal neoplasms - Abdominal hernia - Irritable bowel syndrome - Acute or chronic cholecystitis, hepatitis - Patients who died during surgery - Patients with digestive system tumors |
Country | Name | City | State |
---|---|---|---|
China | Hepatopancreatobiliary Surgery Institute of Gansu Province | Lanzhou | Gansu |
Lead Sponsor | Collaborator |
---|---|
Hepatopancreatobiliary Surgery Institute of Gansu Province |
China,
Buchbinder A, Adler H, Ballard H. An unusual and unreported toxicity to erythropoietin. Am J Hematol. 1993 Apr;42(4):412-3. doi: 10.1002/ajh.2830420428. No abstract available. — View Citation
Gallitto E, Sobocinski J, Mascoli C, Pini R, Fenelli C, Faggioli G, Haulon S, Gargiulo M. Fenestrated and Branched Thoraco-abdominal Endografting after Previous Open Abdominal Aortic Repair. Eur J Vasc Endovasc Surg. 2020 Dec;60(6):843-852. doi: 10.1016/j — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiopulmonary bypass (CPB) time | Was defined it as the sum of times of CPB during surgery (minutes). | 1 month | |
Primary | The AGI score | The AGI score of the patient within the seventh postoperative day was performed according to the European Society of critical care (2012) guidelines for AGI. | 1 month | |
Secondary | Number of bowel sounds | The return time of bowel sounds was evaluated morning and evening. | 1 month | |
Secondary | First defecation time | The time to the first defecation was asked morning and evening after surgery | 1 month | |
Secondary | Proportion of cocci and bacilli in feces | The first feces were collected in sterile containers for the bacterial smear | 1 month | |
Secondary | Alanine aminotransferase (ALT) | We defined it as the maximum value of ALT within 7 days after surgery. | 1 month | |
Secondary | Aspartate aminotransferase (AST) | We defined it as the maximum value of AST within 7 days after surgery | 1 month | |
Secondary | Left ventricular ejection fraction (LVEF) | We measured the LVEF on the 1st and 3rd days after operation by echocardiographic examinations | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02865798 -
China Senile Valvular Heart Disease Cohort Study
|
N/A | |
Completed |
NCT02249000 -
BIOVALVE - I / II Clincial Investigation
|
N/A | |
Completed |
NCT02297334 -
Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery
|
N/A | |
Completed |
NCT01591018 -
SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry
|
Phase 3 | |
Completed |
NCT01428947 -
Does Coronary Angiography Cause Cognitive Dysfunction?
|
N/A | |
Recruiting |
NCT01231776 -
Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary Bypass
|
N/A | |
Terminated |
NCT01116037 -
ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study
|
N/A | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Terminated |
NCT03632967 -
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
|
N/A | |
Recruiting |
NCT05728047 -
Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
|
||
Not yet recruiting |
NCT05539261 -
Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery
|
||
Completed |
NCT05479968 -
Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery
|
||
Completed |
NCT03527381 -
Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT03664102 -
Automated Fastener Device Versus Manually Tied Knot in MiAVR
|
||
Recruiting |
NCT06084091 -
Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
|
||
Completed |
NCT05836467 -
Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?
|
||
Recruiting |
NCT05933083 -
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
|
N/A | |
Recruiting |
NCT04445012 -
Cardiovascular Acoustics and an Intelligent Stethoscope
|
||
Active, not recruiting |
NCT02732691 -
JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study
|
N/A | |
Completed |
NCT02981953 -
TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System
|
N/A |